![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Abbott Japan, Eisai Announce Launch of Pancreatic Digestive Enzyme Replacement Drug Lipacreon
Abbott Japan, Eisai Announce Launch of Pancreatic Digestive Enzyme Replacement Drug Lipacreon
August 29, 2011
Abbott Japan and Eisai announced they will launch the pancreatic digestive enzyme replacement drug Lipacreon Capsules 150 mg and Lipacreon Granules 300 mg Sachets (pancrelipase) in Japan.
MarketWatch
MarketWatch
Upcoming Events
-
21Oct